| Lorenzo Oscar Telleria Jr, MD | |
|
5827 Corporate Way, West Palm Beach, FL 33407-2000 | |
| (561) 844-9443 | |
| Not Available |
| Full Name | Lorenzo Oscar Telleria Jr |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 33 Years |
| Location | 5827 Corporate Way, West Palm Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821674953 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | ME152367 (Florida) | Primary |
| 207RI0200X | Internal Medicine - Infectious Disease | 325973 (Louisiana) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Community Health Centers Inc | 9931017126 | 29 |
News Archive
The Texas House voted 98-49 Sunday night to slash funding for public schools, nursing homes and college financial aid in a dramatic show by Republicans elected on a limited-government message in the face of a massive budget shortfall.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX in the U.S. and Xiapex in Europe, today announced its financial results for the fourth quarter and full year ended December 31, 2015 and provided a corporate update.
Cytune Pharma, an emerging leader in innovative immunomodulatory agents against cancer and infectious diseases, announced today that it will attend the BIO2012 to present its major achievements over the last 12 months and to foster partnering discussions.
Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition that affects approximately 200,000 people a year in the United States and has a higher mortality rate than breast and prostate cancer combined. The condition most often occurs in people who are critically ill or who have significant injuries; those who do survive it often experience profound skeletal muscle weakness.
› Verified 4 days ago
| Entity Name | Florida Community Health Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851518211 PECOS PAC ID: 9931017126 Enrollment ID: O20040515000037 |
News Archive
The Texas House voted 98-49 Sunday night to slash funding for public schools, nursing homes and college financial aid in a dramatic show by Republicans elected on a limited-government message in the face of a massive budget shortfall.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX in the U.S. and Xiapex in Europe, today announced its financial results for the fourth quarter and full year ended December 31, 2015 and provided a corporate update.
Cytune Pharma, an emerging leader in innovative immunomodulatory agents against cancer and infectious diseases, announced today that it will attend the BIO2012 to present its major achievements over the last 12 months and to foster partnering discussions.
Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition that affects approximately 200,000 people a year in the United States and has a higher mortality rate than breast and prostate cancer combined. The condition most often occurs in people who are critically ill or who have significant injuries; those who do survive it often experience profound skeletal muscle weakness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lorenzo Oscar Telleria Jr, MD 5827 Corporate Way, West Palm Beach, FL 33407-2000 Ph: (561) 844-9443 | Lorenzo Oscar Telleria Jr, MD 5827 Corporate Way, West Palm Beach, FL 33407-2000 Ph: (561) 844-9443 |
News Archive
The Texas House voted 98-49 Sunday night to slash funding for public schools, nursing homes and college financial aid in a dramatic show by Republicans elected on a limited-government message in the face of a massive budget shortfall.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX in the U.S. and Xiapex in Europe, today announced its financial results for the fourth quarter and full year ended December 31, 2015 and provided a corporate update.
Cytune Pharma, an emerging leader in innovative immunomodulatory agents against cancer and infectious diseases, announced today that it will attend the BIO2012 to present its major achievements over the last 12 months and to foster partnering discussions.
Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition that affects approximately 200,000 people a year in the United States and has a higher mortality rate than breast and prostate cancer combined. The condition most often occurs in people who are critically ill or who have significant injuries; those who do survive it often experience profound skeletal muscle weakness.
› Verified 4 days ago
Juan C Ramos-canseco, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 901 45th St, West Palm Beach, FL 33407 Phone: 561-882-6214 Fax: 561-882-6216 | |
Mira Baron, MD, CPI Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2277 Palm Beach Lakes Blvd, West Palm Beach, FL 33409 Phone: 561-689-0606 Fax: 561-689-0654 | |
William Kaye, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1515 N Flagler Dr, Suite 430, West Palm Beach, FL 33401 Phone: 561-659-6336 Fax: 561-659-2150 | |
Dr. Clare Louise Dana, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 7305 N. Military Trail, Medicine (111), West Palm Beach, FL 33410 Phone: 561-422-6650 Fax: 561-422-8708 | |
Dr. Gerard Jean-baptiste, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1266 N Military Trl, West Palm Beach, FL 33409 Phone: 561-687-8685 Fax: 561-683-2279 | |
Dr. Mousa Michael Hanna, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1411 N Flagler Dr, Suite 6300, West Palm Beach, FL 33401 Phone: 561-659-6023 Fax: 561-659-6025 | |
Dr. Anita Michelle Wilborn, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 N Flagler Dr, Suite 3, West Palm Beach, FL 33407 Phone: 561-655-9417 Fax: 561-655-9804 |